Leeward Investments LLC MA Sells 31,283 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Leeward Investments LLC MA decreased its position in Option Care Health, Inc. (NASDAQ:OPCH) by 7.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 401,629 shares of the company’s stock after selling 31,283 shares during the quarter. Leeward Investments LLC MA owned approximately 0.24% of Option Care Health worth $9,318,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of OPCH. Creative Planning raised its position in shares of Option Care Health by 116.7% in the third quarter. Creative Planning now owns 38,149 shares of the company’s stock valued at $1,194,000 after purchasing an additional 20,546 shares during the period. Blue Trust Inc. increased its position in Option Care Health by 37.2% during the third quarter. Blue Trust Inc. now owns 4,022 shares of the company’s stock worth $126,000 after acquiring an additional 1,091 shares during the period. Raymond James & Associates increased its position in Option Care Health by 6.3% during the third quarter. Raymond James & Associates now owns 85,279 shares of the company’s stock worth $2,669,000 after acquiring an additional 5,049 shares during the period. International Assets Investment Management LLC increased its position in Option Care Health by 3,029.7% during the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock worth $91,000 after acquiring an additional 2,757 shares during the period. Finally, Wealth Enhancement Advisory Services LLC bought a new position in Option Care Health during the third quarter worth $206,000. Institutional investors own 98.05% of the company’s stock.

Option Care Health Trading Down 1.2 %

Shares of Option Care Health stock opened at $32.00 on Friday. The firm has a market capitalization of $5.45 billion, a PE ratio of 26.89, a price-to-earnings-growth ratio of 2.30 and a beta of 1.35. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The company’s fifty day moving average price is $27.71 and its two-hundred day moving average price is $27.98. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $34.63.

Wall Street Analyst Weigh In

OPCH has been the topic of a number of research reports. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. UBS Group initiated coverage on shares of Option Care Health in a research report on Thursday, December 5th. They set a “neutral” rating and a $26.00 target price on the stock. Truist Financial dropped their target price on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Finally, The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their price target for the company from $38.00 to $27.00 in a report on Monday, November 4th. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $32.25.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.